NOTE 11 - STOCKHOLDERS' DEFICIENCY: Recapitalization (Details) - shares |
12 Months Ended | |
|---|---|---|
Dec. 31, 2020 |
Dec. 31, 2019 |
|
| Common Stock, Shares Authorized | 1,200,000,000 | 1,200,000,000 |
| Transaction 1 | ||
| Sale of Stock, Transaction Date | May 01, 2019 | |
| Common Stock, Shares Authorized | 1,200,000,000 |
| X | ||||||||||
- Definition The maximum number of common shares permitted to be issued by an entity's charter and bylaws. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Date the subsidiary or equity investee issued or sold stock, in CCYY-MM-DD format. No definition available.
|
| X | ||||||||||
- Details
|